Third-line treatment in metastatic renal cell carcinoma and bone metastases

被引：0
|
作者：
Heng, Daniel Y. C. [1 ]
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2015年 / 9卷 / 7-8期
关键词：
D O I：
10.5489/cuaj.3238
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [21] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Third-line sunitinib following sequential use of cytokine therapy and sorafenib in Japanese patients with metastatic renal cell carcinoma
    Hideaki Miyake
    Yuji Kusuda
    Ken-ichi Harada
    Iori Sakai
    Masato Fujisawa
    International Journal of Clinical Oncology, 2013, 18 : 81 - 86
  • [23] Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer
    Zardavas, Dimitrios
    Meisel, Alexander
    Samaras, Panagiotis
    Knuth, Alexander
    Renner, Christoph
    Pestalozzi, Bernhard C.
    Stenner-Liewen, Frank
    CASE REPORTS IN ONCOLOGY, 2011, 4 (01): : 16 - 18
  • [24] Surgical treatment of pulmonary metastases in metastatic renal cell carcinoma
    Gilbert, Nils
    AKTUELLE UROLOGIE, 2020, 51 (03) : 271 - 274
  • [25] Delphi consensus for the third-line treatment of metastatic colorectal cancer
    Garcia-Alfonso, Pilar
    Vera, Ruth
    Aranda, Enrique
    Elez, Elena
    Rivera, Fernando
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (06): : 1429 - 1437
  • [26] Sequencing Considerations in the Third-Line Treatment of Metastatic Colorectal Cancer
    Barzi, Afsaneh
    Bekaii-Saab, Tanios
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02): : S31 - S35
  • [27] Proactive Transitioning to Third-Line Treatment in Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 5 - 7
  • [28] Optimizing Administration of Third-Line Treatment in Metastatic Colorectal Cancer
    Prager, Gerald W.
    Ducreux, Michel
    Argiles, Guillem
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 1 - 20
  • [29] Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma
    Zhang, Bin
    Li, Rui
    Chang, Chun-Xiao
    Han, Yong
    Shi, Sheng-Bin
    Tian, Jing
    ONCOTARGETS AND THERAPY, 2016, 9 : 3901 - 3906
  • [30] Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial
    Motzer, Robert J.
    Porta, Camillo
    Vogelzang, Nicholas J.
    Sternberg, Cora N.
    Szczylik, Cezary
    Zolnierek, Jakub
    Kollmannsberger, Christian
    Rha, Sun Young
    Bjarnason, Georg A.
    Melichar, Bohuslav
    De Giorgi, Ugo
    Gruenwald, Viktor
    Davis, Ian D.
    Lee, Jae-Lyun
    Esteban, Emilio
    Urbanowitz, Gladys
    Cai, Can
    Squires, Matthew
    Marker, Mahtab
    Shi, Michael M.
    Escudier, Bernard
    LANCET ONCOLOGY, 2014, 15 (03): : 286 - 296
12345